LD-110
LD-110 is a highly efficient and effective PROTAC degrader targeting LSD1 (DC50 = 0.44 μM). LD-110 promotes LSD1 degradation and increases the level of H3K4 dimethylation in a ubiquitin-proteasome-dependent manner. LD-110 inhibits the growth and survival of multiple esophagus squamous cancer cell (ESCC) lines by inducing apoptosis. LD-110 can be used for the study of esophagus squamous cancer. Red: LSD1 ligand ; Blue: E3 ligase CRBN ligand (HY-14658) ; Black: Linker (HY-N2578).
Product Specifications
UNSPSC
12352005
Target
Apoptosis; Histone Demethylase; PROTACs
Related Pathways
Apoptosis; Epigenetics; PROTAC
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Smiles
O=C(NCCCCNC1=CC2=C(C(N(C(CC3)C(NC3=O)=O)C2=O)=O)C=C1)C4=CC=C(C5=NC=C(OCC6CCNCC6)C=C5C7=CC=C(C#N)C=C7)C=C4
Molecular Formula
C42H41N7O6
Molecular Weight
739.82
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Chicken Muscarinic Acetylcholine Receptor ELISA Kit
Camel Macrophage Erythroblast Attacher (MAEA) ELISA Kit
Recombinant Human Lymphocyte antigen 6L (LY6L)